Navigation Links
Unilife to Present at the Jefferies 2013 Global Healthcare Conference in New York City on June 4th
Date:5/31/2013

YORK, Pa., May 31, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its CEO, Alan Shortall will be presenting at the Jefferies 2013 Global Healthcare Conference in New York City at 12:30 p.m. EDT on Tuesday, June 4, 2013.

The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.

About Unilife CorporationUnilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's extensive portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, intraocular delivery systems and specialized devices. Each of these innovative, differentiated platforms can be customized by Unilife to address specific customer, drug and patient requirements. Unilife's global headquarters and advanced manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.

General: UNIS-G Investor Contacts (US):
Analyst Enquiries
Investor Contacts (Australia)Todd Fromer / Garth RussellLynn PieperJeff CarterKCSA Strategic CommunicationsWestwicke PartnersUnilife CorporationP: + 1 212-896-1215 / 212-896-125P: + 1 415-202-5678P: + 61 2 8346 6500 


'/>"/>
SOURCE Unilife Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
2. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
3. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
4. Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
5. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
6. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
7. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
9. Unilifes Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
10. Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
11. Unilife to Present at the Lazard 9th Annual Healthcare Conference in New York City on November 13th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... , ... February 20, 2020 ... ... leader in government program modernization, has been selected to perform Independent Verification ... Human Services’ (EOHHS) Health Insurance Exchange and Integrated Eligibility System (HIX/IES) project. ...
(Date:2/19/2020)... ... February 19, 2020 , ... Cancer ... Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as ... market for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing ...
(Date:2/19/2020)... ... , ... The swine flu (H1N1) was the virus that spread from animals ... outbreak. Although the U.S. has eradicated this disease after its first and only ... world, posing a risk from trading partners. , In a new article released ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Stem Cell, the nation's ... to complete 70 complimentary stem cell procedures on military veterans in 2019. ... no cost. , At the R3 Stem Cell Training Course for doctors , providers ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Richard Amato, ... Center of Connecticut, celebrate 30 years of serving Monroe, CT with a “Throwback ... that they charged in 1989, only thirty dollars. To further serve their patients, ...
(Date:2/19/2020)... ... February 19, 2020 , ... In ... scope of regulations and requirements that currently govern medical device manufacturers under the ... extends until 25 May 2020. Major changes from the previous MDD include:, ...
(Date:2/19/2020)... ... February 19, 2020 , ... SafiraMD Medical Aesthetics ... FDA-cleared CoolSculpting®, the world’s most popular non-invasive fat reduction treatment. Their CoolEvent will ... Halcyon Village Center in Alpharetta, Georgia. The CoolEvent will feature live demonstrations, exclusive ...
(Date:2/15/2020)... ... February 14, 2020 , ... Sister companies, Special Learning Inc. and ... IN ABA”. The series explores the challenges, risks, and opportunities of private equity ... on March 25, 2020 at: https://bit.ly/2OU6lxg , Since 2010, more than ...
Breaking Medicine News(10 mins):